Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women

被引:159
作者
Goodman-Gruen, D [1 ]
Barrett-Connor, E [1 ]
机构
[1] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA
关键词
D O I
10.2337/diacare.23.7.912
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Some evidence suggests an inverse association between type 2 diabetes and androgens in men and a positive association between type 2 diabetes and androgens in women. The purpose of this community-based study was to evaluate sex differences in the association between endogenous total and bioavailable estrogen and testosterone levels and glucose tolerance status. RESEARH DESIGN AND METHODS - We included in this study 775 men and 633 postmenopausal non-estrogen-using women, all greater than or equal to 55 years of age (mean ages 72 and 75 years, respectively). A 75-g oral glucose tolerance test (OGTT) was administered to fasting subjects from 1984 to 1987, when sera were frozen for measurement of total and bioavailable hormone levels. Total testosterone and estradiol levels were measured by radioimmunoassay, and bioavailable hormone levels were determined using a modified ammonium-sulfate precipitation method. The association between steroid hormones and glucose tolerance status was tested. RESULTS - In sex-specific age- and BMI-adjusted analyses, men with impaired glucose tolerance (IGT) had significantly lower total testosterone levels. Women with IGT or type 2 diabetes had significantly higher bioavailable testosterone and total and bioavailable estradiol levels than those with normal glucose tolerance. Total testosterone and fasting plasma glucose were inversely associated in men (P = 0.0001), whereas bioavailable testosterone and estradiol were positively associated with fasting plasma glucose in women (P = 0.0001 and 0.001, respectively). CONCLUSIONS - Additional studies are needed to further develop the hormone-diabetes connection.
引用
收藏
页码:912 / 918
页数:7
相关论文
共 63 条
  • [11] BOLELLI G, 1995, CANCER EPIDEM BIOMAR, V4, P509
  • [12] RELATIONSHIPS BETWEEN COMPUTED-TOMOGRAPHY TISSUE AREAS, THICKNESSES AND TOTAL-BODY COMPOSITION
    BORKAN, GA
    HULTS, DE
    GERZOF, SG
    BURROWS, BA
    ROBBINS, AH
    [J]. ANNALS OF HUMAN BIOLOGY, 1983, 10 (06) : 537 - 546
  • [13] Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM
    Brussaard, HE
    Leuven, JAG
    Frolich, M
    Kluft, C
    Krans, HMJ
    [J]. DIABETOLOGIA, 1997, 40 (07) : 843 - 849
  • [14] CORRELATION OF HYPERANDROGENISM WITH HYPERINSULINISM IN POLYCYSTIC OVARIAN DISEASE
    BURGHEN, GA
    GIVENS, JR
    KITABCHI, AE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 50 (01) : 113 - 116
  • [15] THE EPIDEMIOLOGY OF SERUM SEX-HORMONES IN POSTMENOPAUSAL WOMEN
    CAULEY, JA
    GUTAI, JP
    KULLER, LH
    LEDONNE, D
    POWELL, JG
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 129 (06) : 1120 - 1131
  • [16] RELIABILITY AND INTERRELATIONS AMONG SERUM SEX-HORMONES IN POSTMENOPAUSAL WOMEN
    CAULEY, JA
    GUTAI, JP
    KULLER, LH
    POWELL, JG
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 133 (01) : 50 - 57
  • [17] INSULIN RESISTANCE IN NON-OBESE PATIENTS WITH POLYCYSTIC OVARIAN DISEASE
    CHANG, RJ
    NAKAMURA, RM
    JUDD, HL
    KAPLAN, SA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (02) : 356 - 359
  • [18] CHANG TC, 1994, GERONTOLOGY, V40, P260
  • [19] Hormonal status and NIDDM in the European and Melanesian populations of New Caledonia:: a case-control study
    Defay, R
    Papoz, L
    Barny, S
    Bonnot-Lours, S
    Cacès, E
    Simon, D
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (09) : 927 - 934
  • [20] CIRCULATING GONADOTROPINS, ESTROGENS, AND ANDROGENS IN POLYCYSTIC OVARIAN DISEASE
    DEVANE, GW
    CZEKALA, NM
    JUDD, HL
    YEN, SSC
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1975, 121 (04) : 496 - 500